Neurexophilin 1 suppresses the proliferation of hematopoietic progenitor cells.

Abstract:

:Neurexin I α (NRXN1α) and Dystroglycan (DAG1) are membrane receptors which serve as mutual ligands in the neuronal system. Neurexophilins (NXPHs) bind NRXN1α. NRXN1α was expressed in primitive populations in human CB (huCB) and murine BM (muBM). DAG1 is ubiquitously expressed in hematopoietic tissue; however, osteoblasts appear to be sites of very high expression within muBM. High concentrations of NXPH were found in huCB plasma and murine lineage-positive splenocytes. We evaluated effects of these molecules on huCB and muBM hematopoietic progenitor cells (HPCs) and HSCs. At both a single and population cell level in vitro, we found that NXPH1 was a potent inhibitor of HPC proliferation acting through NRXN1α an effect down-modulated by DAG1. Injection of recombinant NXPH1 in vivo resulted in myelo- and lymphosuppression in the BM, with absolute numbers and cycling status of functional and phenotypically defined HPCs dose- and time-dependently decreased. Competitive HSC transplantations showed no change in the long-term repopulating activity of HSCs from mice exposed to recombinant NXPH1. These results demonstrate the presence and function of a regulated signaling axis in hematopoiesis centered on NRXN1α and its modulation by DAG1 and NXPH1.

journal_name

Blood

journal_title

Blood

authors

Kinzfogl J,Hangoc G,Broxmeyer HE

doi

10.1182/blood-2010-12-325381

subject

Has Abstract

pub_date

2011-07-21 00:00:00

pages

565-75

issue

3

eissn

0006-4971

issn

1528-0020

pii

blood-2010-12-325381

journal_volume

118

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Second to none.

    abstract::In this issue of Blood, Usmani et al provide important information on second primary malignancies in patients treated with thalidomide and lenalidomide in the Arkansas total therapy trials. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-07-439158

    authors: Rajkumar SV

    更新日期:2012-08-23 00:00:00

  • The Senegal DNA haplotype is associated with the amelioration of anemia in African-American sickle cell anemia patients.

    abstract::We have previously determined that in African sickle cell anemia (SS) patients three different beta-like globin gene cluster haplotypes are associated with different percent G gamma (one of the two types of non-alpha chains comprising hemoglobin F [HbF]), mean percent HbF, and percent dense cells. We report now that i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nagel RL,Erlingsson S,Fabry ME,Croizat H,Susuka SM,Lachman H,Sutton M,Driscoll C,Bouhassira E,Billett HH

    更新日期:1991-03-15 00:00:00

  • Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome.

    abstract::To evaluate internal tandem duplication (ITD) insertion sites and length as well as their clinical impact in younger adult patients with FLT3-ITD-positive acute myeloid leukemia (AML), sequencing after DNA-based amplification was performed in diagnostic samples from 241 FLT3-ITD-mutated patients. All patients were tre...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2009-03-209999

    authors: Kayser S,Schlenk RF,Londono MC,Breitenbuecher F,Wittke K,Du J,Groner S,Späth D,Krauter J,Ganser A,Döhner H,Fischer T,Döhner K,German-Austrian AML Study Group (AMLSG).

    更新日期:2009-09-17 00:00:00

  • How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage).

    abstract::Indolent systemic mastocytosis (SM) patients have a varied clinical presentation, ranging from predominantly cutaneous symptoms to recurrent systemic symptoms (eg, flushing, palpitations, dyspepsia, diarrhea, bone pain) that can be severe and potentially life threatening (anaphylaxis). Mastocytosis patients without sk...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-01-453183

    authors: Pardanani A

    更新日期:2013-04-18 00:00:00

  • The Hermansky-Pudlak syndrome 1 (HPS1) and HPS2 genes independently contribute to the production and function of platelet dense granules, melanosomes, and lysosomes.

    abstract::Hermansky-Pudlak syndrome (HPS) is an inherited hemorrhagic disease affecting the related subcellular organelles platelet dense granules, lysosomes, and melanosomes. The mouse genes for HPS, pale ear and pearl, orthologous to the human HPS1 and HPS2 (ADTB3A) genes, encode a novel protein of unknown function and the be...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Feng L,Novak EK,Hartnell LM,Bonifacino JS,Collinson LM,Swank RT

    更新日期:2002-03-01 00:00:00

  • Development of an in vivo model of human multiple myeloma bone disease.

    abstract::Osteolytic bone destruction and its complications, bone pain, pathologic fractures, and hypercalcemia, are a major source of morbidity and mortality in patients with multiple myeloma. The bone destruction in multiple myeloma is due to increased osteoclast (OCL) activity and decreased bone formation in areas of bone ad...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Alsina M,Boyce B,Devlin RD,Anderson JL,Craig F,Mundy GR,Roodman GD

    更新日期:1996-02-15 00:00:00

  • The impact of low-dose busulfan on clonal dynamics in nonhuman primates.

    abstract::An understanding of the number and contribution of individual pluripotent hematopoietic stem cells (HSCs) to the formation of blood lineages has important clinical implications for gene therapy and stem cell transplantation. We have been able to efficiently mark rhesus macaque long-term repopulating stem and progenito...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-08-2935

    authors: Kuramoto K,Follman D,Hematti P,Sellers S,Laukkanen MO,Seggewiss R,Metzger ME,Krouse A,Donahue RE,von Kalle C,Dunbar CE

    更新日期:2004-09-01 00:00:00

  • The C-class chemokine lymphotactin costimulates the apoptosis of human CD4(+) T cells.

    abstract::Clonal expansion of activated T cells is controlled by homeostatic mechanisms leading to cell death of a large proportion of the cells. The CD3/TcR pathway induces cell death, mostly when triggered in the absence of costimulatory signal. The unique T cell-specific chemokine of the C class, lymphotactin (Lptn), has rec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.8.2205

    authors: Cerdan C,Devilard E,Xerri L,Olive D

    更新日期:2001-04-15 00:00:00

  • Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation.

    abstract::Chronic myeloid leukemia (CML) patients with the BCR-ABL T315I mutation do not benefit from therapy with currently approved tyrosine kinase inhibitors. Omacetaxine mepesuccinate is a protein synthesis inhibitor that has demonstrated activity in cells harboring the T315I mutation. This phase 2 trial assessed the effica...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2012-03-415307

    authors: Cortes J,Lipton JH,Rea D,Digumarti R,Chuah C,Nanda N,Benichou AC,Craig AR,Michallet M,Nicolini FE,Kantarjian H,Omacetaxine 202 Study Group.

    更新日期:2012-09-27 00:00:00

  • Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion.

    abstract::The present studies were undertaken to determine whether factor VIII/von Willebrand factor (vWF) present in the vessel wall (in addition to that in plasma) may mediate the attachment of platelets to subendothelium. Subendothelium from everted rabbit aorta was exposed to human citrated blood flowing through an annular ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Turitto VT,Weiss HJ,Zimmerman TS,Sussman II

    更新日期:1985-04-01 00:00:00

  • Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells.

    abstract::As B-cell chronic lymphocytic leukemia (B-CLL) progresses, malignant cells extravasate and infiltrate lymphoid tissues. Several molecules, including gelatinase B/MMP-9, contribute to these processes. Although mainly a secreted protease, some MMP-9 is present at the B-CLL cell surface and the function, mode of anchorin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-08-109249

    authors: Redondo-Muñoz J,Ugarte-Berzal E,García-Marco JA,del Cerro MH,Van den Steen PE,Opdenakker G,Terol MJ,García-Pardo A

    更新日期:2008-07-01 00:00:00

  • Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane.

    abstract::Previous studies suggested a role for prostaglandins or thromboxane A2, or both in the exposure of fibrinogen receptors on normal platelets in response to several aggregating agents. Platelets from diabetics are known to be more sensitive to aggregating agents and to produce more prostaglandins and thromboxane than pl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: DiMinno G,Silver MJ,Cerbone AM,Riccardi G,Rivellese A,Mancini M,Thiagarajan P

    更新日期:1985-01-01 00:00:00

  • Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus.

    abstract::Eosinophils are recruited to the lungs in response to respiratory syncytial virus (RSV) infection; however, their role in promoting antiviral host defense remains unclear. Here, we demonstrate that eosinophils express TLRs that recognize viral nucleic acids, are activated and degranulate after single-stranded RNA (ssR...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-071340

    authors: Phipps S,Lam CE,Mahalingam S,Newhouse M,Ramirez R,Rosenberg HF,Foster PS,Matthaei KI

    更新日期:2007-09-01 00:00:00

  • HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4(+) T lymphocytes.

    abstract::Bcr-abl fusion peptide-specific CD4+ T-lymphocyte clones have recently been shown to augment colony formation by chronic myelogenous leukemia (CML) cells in a bcr-abl type-specific and HLA class II-restricted manner without addition of exogenous antigen. These findings suggest that CML cells can naturally process and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.5.1498

    authors: Yasukawa M,Ohminami H,Kojima K,Hato T,Hasegawa A,Takahashi T,Hirai H,Fujita S

    更新日期:2001-09-01 00:00:00

  • CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique.

    abstract::CD4(+), CD56(+) DC2 malignancies constitute a novel disease entity, which has recently been shown to arise from a transformed lymphoid-related plasmacytoid dendritic cell (DC2). Diagnosis is primarily based on a particular immunophenotype with tumor cells expressing CD4 and CD56 antigens in the absence of common lymph...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood.v99.11.4154

    authors: Leroux D,Mugneret F,Callanan M,Radford-Weiss I,Dastugue N,Feuillard J,Le Mée F,Plessis G,Talmant P,Gachard N,Uettwiller F,Pages MP,Mozziconacci MJ,Eclache V,Sibille C,Avet-Loiseau H,Lafage-Pochitaloff M

    更新日期:2002-06-01 00:00:00

  • Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire.

    abstract::The human peripheral B-cell compartment displays a large population of immunoglobulin M-positive, immunoglobulin D-positive CD27(+) (IgM(+)IgD(+)CD27(+)) "memory" B cells carrying a mutated immunoglobulin receptor. By means of phenotypic analysis, complementarity-determining region 3 (CDR3) spectratyping during a T-in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-01-0346

    authors: Weller S,Braun MC,Tan BK,Rosenwald A,Cordier C,Conley ME,Plebani A,Kumararatne DS,Bonnet D,Tournilhac O,Tchernia G,Steiniger B,Staudt LM,Casanova JL,Reynaud CA,Weill JC

    更新日期:2004-12-01 00:00:00

  • Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease.

    abstract::Fas ligand (FasL) and perforin pathways not only are the major mechanisms of T cell-mediated cytotoxicity but also are involved in homeostatic regulation of these T cells. In the present study, we tested whether CD8+ donor T cells that are deficient in both perforin and FasL (cytotoxic double deficient [cdd]) could in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-08-3036

    authors: Maeda Y,Levy RB,Reddy P,Liu C,Clouthier SG,Teshima T,Ferrara JL

    更新日期:2005-03-01 00:00:00

  • Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation.

    abstract::Pediatric-type follicular lymphoma (PTFL) is a B-cell lymphoma with distinctive clinicopathological features. Recently, recurrent genetic alterations of potential importance for its pathogenesis that disrupt pathways associated with the germinal center reaction (TNFRSF14, IRF8), immune escape (TNFRSF14), and anti-apop...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-03-776278

    authors: Schmidt J,Ramis-Zaldivar JE,Nadeu F,Gonzalez-Farre B,Navarro A,Egan C,Montes-Mojarro IA,Marafioti T,Cabeçadas J,van der Walt J,Dojcinov S,Rosenwald A,Ott G,Bonzheim I,Fend F,Campo E,Jaffe ES,Salaverria I,Quintanilla-M

    更新日期:2017-07-20 00:00:00

  • Importance of subsegmental pulmonary embolism.

    abstract::In this issue of Blood, den Exter et al highlight the importance of subsegmental pulmonary emboli. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2013-06-508440

    authors: Raskob GE

    更新日期:2013-08-15 00:00:00

  • TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation.

    abstract::Regulatory dendritic cells (DCs) play an important role in maintaining peripheral tolerance or immune homeostasis. Our previous study demonstrated that mature DCs could be driven by splenic stroma to proliferate and differentiate into a novel subset of regulatory DCs (diffDCs) displaying a Th2-biased cytokine profile....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-03-005595

    authors: Qian C,Jiang X,An H,Yu Y,Guo Z,Liu S,Xu H,Cao X

    更新日期:2006-10-01 00:00:00

  • Sickle cell and silent spleen.

    abstract::In this issue of Blood, in a first-rate example of collaboration between academia (University of California) and industry (Sangamo), Hoban et al show in situ gene correction of sickle cell anemia (SCA), a prototypical hemoglobinopathy. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-03-633933

    authors: Tolar J

    更新日期:2015-04-23 00:00:00

  • CD38 antibodies in multiple myeloma: back to the future.

    abstract::CD38 is highly and uniformly expressed on multiple myeloma (MM) cells, and at relatively low levels on normal lymphoid and myeloid cells, and in some tissues of nonhematopoietic origin. CD38 is a transmembrane glycoprotein with ectoenzymatic activity, and also functions as a receptor and adhesion molecule. Altogether,...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-06-740944

    authors: van de Donk NWCJ,Richardson PG,Malavasi F

    更新日期:2018-01-04 00:00:00

  • Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets.

    abstract::Cure of hematologic malignancies after allogeneic hematopoietic stem cell transplantation is partially attributable to immunocellular antitumor reactions termed graft-versus-tumor (GvT) effect. GvT effects are heterogeneous with respect to effector cell populations, target antigens, and their interrelation with graft-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-10-3387

    authors: Stelljes M,Strothotte R,Pauels HG,Poremba C,Milse M,Specht C,Albring J,Bisping G,Scheffold C,Kammertoens T,Oelmann E,Silling G,Berdel WE,Kienast J

    更新日期:2004-08-15 00:00:00

  • Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.

    abstract::Protein S is a vitamin K-dependent nonenzymatic anticoagulant protein that acts as a cofactor to activated protein C. Recently it was shown that protein S inhibits the prothrombinase reaction independent of activated protein C. In this study, we show that protein S can also inhibit the intrinsic factor X activation vi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Koppelman SJ,Hackeng TM,Sixma JJ,Bouma BN

    更新日期:1995-08-01 00:00:00

  • Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.

    abstract::Lenalidomide, bortezomib, and dexamethasone (RVd) followed by autologous stem cell transplantation (ASCT) is standard frontline therapy for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM). The addition of daratumumab (D) to RVd (D-RVd) in transplant-eligible NDMM patients was evaluated. Patie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005288

    authors: Voorhees PM,Kaufman JL,Laubach J,Sborov DW,Reeves B,Rodriguez C,Chari A,Silbermann R,Costa LJ,Anderson LD Jr,Nathwani N,Shah N,Efebera YA,Holstein SA,Costello C,Jakubowiak A,Wildes TM,Orlowski RZ,Shain KH,Cowan AJ,

    更新日期:2020-08-20 00:00:00

  • Deregulation of TWIST-1 in the CD34+ compartment represents a novel prognostic factor in chronic myeloid leukemia.

    abstract::The mechanisms of resistance to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) often remain obscure. Analysis of patient samples during disease progression revealed the up-regulation of the oncogene TWIST-1, also measured in primary samples from TKI-resistant patients. Moreover, we found that TWIS...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-11-254680

    authors: Cosset E,Hamdan G,Jeanpierre S,Voeltzel T,Sagorny K,Hayette S,Mahon FX,Dumontet C,Puisieux A,Nicolini FE,Maguer-Satta V

    更新日期:2011-02-03 00:00:00

  • Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1.

    abstract::We analyzed the expression of myelomonocytic-associated antigens on lymphocytes from B cell chronic lymphocytic leukemia (B-CLL) patients. Blood mononuclear cells were depleted of monocytes by one-step Percoll density gradient centrifugation and tested for antigen expression by fluorescent microscopy and flow cytometr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morabito F,Prasthofer EF,Dunlap NE,Grossi CE,Tilden AB

    更新日期:1987-12-01 00:00:00

  • IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo.

    abstract::Interleukin 21 (IL-21) is a member of the common gamma-chain family of cytokines, which influence a broad spectrum of immunologic responses. A number of studies have examined the function of IL-21, but its specific role in Th1/Th2-cell differentiation and related effector responses remains to be clarified. Thus, we ge...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-021600

    authors: Fröhlich A,Marsland BJ,Sonderegger I,Kurrer M,Hodge MR,Harris NL,Kopf M

    更新日期:2007-03-01 00:00:00

  • Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6.

    abstract::Hepcidin is the master regulator of iron homeostasis. In the liver, iron-dependent hepcidin activation is regulated through Bmp6 and its membrane receptor hemojuvelin (Hjv), whereas, in response to iron deficiency, hepcidin repression seems to be controlled by a pathway involving the serine protease matriptase-2 (enco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-295147

    authors: Lenoir A,Deschemin JC,Kautz L,Ramsay AJ,Roth MP,Lopez-Otin C,Vaulont S,Nicolas G

    更新日期:2011-01-13 00:00:00

  • Molecular and cellular effects of antisickling concentrations of alkylureas.

    abstract::Alkylureas are capable of inhibiting sickling in vitro and the gelation of solutions of hemoglobin S at concentrations between 0.05 and 0.1 M with increasing effectiveness that is directly proportional to the length of the alkyl chain (butyl greater than propyl greater than ethyl greater than methyl). 6The inhibitory ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Elbaum D,Roth EF Jr,Neumann G,Jaffé ER,Bookchin RM,Nagel RL

    更新日期:1976-08-01 00:00:00